JSJian Sun

Jian Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jian Sun has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Junren Wang

    Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China

    2 shared publications
  • Wenxin Ren

    Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China

    2 shared publications
  • Bin Shang

    Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University

    1 shared publication
  • Bin Shang

    Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

    1 shared publication
  • Chunyan Xing

    Department of Pulmonary and Critical Care Medicine, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China

    1 shared publication
  • Shujuan Jiang

    Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University

    1 shared publication

Latest Publications

  • Clinical Characteristics and Economic Burden of Asthma in China: A Multicenter Retrospective Study

    by Bin Shang, Xiangguo Li, Yu Xu, Wenxin Ren, Junren Wang, Chunyan Xing, Shujuan Jiang, Jian Sun

    Asthma is a common chronic airway inflammation that produces a healthcare burden on the economy. We aim to obtain a better understanding of the clinical status and disease burden of patients with asthma in China. A retrospective study was carried out based on the computerized medical records in the Jinan Health Medical Big Data Platform between 2011 and 2019 (available data from 38 hospitals). The asthma severity of each patient was assessed retrospectively and categorized as mild, moderate, or severe according to Global Initiative for Asthma 2020 (GINA 2020). The results revealed that the majority (75.0%) of patients suffered from mild asthma. Patients treated with inhaled corticosteroids (ICS)/long-acting beta-agonists (LABA) at emergency department visits had lower frequencies of exacerbations compared with non-ICS/LABA-treated patients. The incidence rates for 1, 2, 3, and 4 exacerbation of the patients treated with ICS/LABA are lower than those treated without ICS/LABA (14.49 vs. 15.01%, 11.94% vs. 19.12%, 6.51% vs. 12.92% and 4.10% vs. 9.35%). The difference got a statistical significance Chronic obstructive pulmonary disease (COPD) and gastroesophageal reflux disease (GERD), two comorbidities related to asthma, were risk factors for asthma exacerbation. Finally, patients who suffered from exacerbations produced a heavier economic burden compared to the patients who never suffered exacerbations (mean costs are ¥3,339.67 vs. ¥968.45 separately). These results provide a reference for clinicians and patients to obtain a better treatment and therapy strategy management for people living with asthma.


  • Open Access

    Clinical Characteristics and Economic Burden of Asthma in China: A Multicenter Retrospective Study

    by Bin Shang, Xiangguo Li, Yu Xu, Wenxin Ren, Junren Wang, Shujuan Jiang, Jian Sun

    Background: Asthma is a common chronic airway inflammation that produces a healthcare burden on the economy. To obtain a better understanding of the clinical status and disease burden of patients with asthma in China. Methods: A retrospective study based on the computerized medical records in the Jinan Health Medical Big Data Platform between 2011 and 2019 (n = 31,082) was carried out. The asthma severity of each patient was assessed retrospectively and categorized as mild, moderate, or severe according to GINA 2018. Results: The results revealed that the majority (75.0%) of patients suffered from mild asthma. Patients treated with ICS/LABA at emergency department visits had lower frequencies of exacerbations in the following year compared with non-ICS/LABA treated patients.The incidence rates for 1 exacerbation are 14.49% vs 15.01 for the patients treated with ICS/LABA and without. The rates are 11.94% and 19.12% for 2 exacerbations above. The numbers are 6.51% vs 12.92% for 3 exacerbations above. The rates are 4.10% vs 9.35% for 4 exacerbations above. Also the difference got the statistical significance(p Conclusions: These results provide a reference for clinicians and patients to obtain a better treatment and therapy strategy management for asthma sufferers.